Comparative Pharmacology
Head-to-head clinical analysis: CYCLOCORT versus TRIDESILON.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CYCLOCORT versus TRIDESILON.
CYCLOCORT vs TRIDESILON
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Topical corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive actions. Suppresses cytokine production, inhibits phospholipase A2, and reduces prostaglandin synthesis.
Desonide is a corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. It acts by inducing phospholipase A2 inhibitory proteins, collectively called lipocortins, which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of arachidonic acid from membrane phospholipids.
Apply a thin film topically to affected area twice daily (morning and evening). Not for ophthalmic use.
0.05% ointment or cream applied topically to affected area twice daily.
None Documented
None Documented
3.5 hours (terminal); clinical effect duration longer due to tissue binding.
2–3 hours (topical); 1–2 hours (systemic) after IV, with clinical duration prolonged due to tissue binding.
Primarily hepatic metabolism; inactive metabolites excreted renally (<1% unchanged) and in feces (biliary).
Primarily hepatic metabolism; metabolites excreted renally (70%) and in feces (30%).
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid